n(1)-methylnicotinamide has been researched along with Cancer of Ovary in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kilgour, MK | 1 |
| MacPherson, S | 1 |
| Zacharias, LG | 1 |
| Ellis, AE | 1 |
| Sheldon, RD | 1 |
| Liu, EY | 1 |
| Keyes, S | 1 |
| Pauly, B | 1 |
| Carleton, G | 1 |
| Allard, B | 1 |
| Smazynski, J | 1 |
| Williams, KS | 1 |
| Watson, PH | 1 |
| Stagg, J | 1 |
| Nelson, BH | 1 |
| DeBerardinis, RJ | 1 |
| Jones, RG | 1 |
| Hamilton, PT | 1 |
| Lum, JJ | 1 |
1 other study available for n(1)-methylnicotinamide and Cancer of Ovary
| Article | Year |
|---|---|
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer.
Topics: Ascites; Female; Humans; Niacinamide; Ovarian Neoplasms; Tumor Microenvironment | 2021 |